In 20 BOS patients, analysis of miR-144 showed a 4-fold increase in BOS patients with a parallel reduction of its target, TGF-β–induced factor homeobox 1 (TGIF1) (20). The gene discussed is TGIF1; the disease is Buschke-Ollendorff syndrome.